GI
PFE icon

GAMMA Investing’s Pfizer PFE Stock Holding History

GAMMA Investing’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.06M Buy
107,263
+21,561
+25% +$573K 0.1% 152
2026
Q2 		$2.06M Buy
85,702
+1,868
+2% +$48.9K 0.08% 206
2026
Q1 		$2.35M Buy
83,834
+12,548
+18% +$334K 0.11% 161
2025
Q4 		$1.78M Sell
71,286
-63
-0.1% -$1.59K 0.09% 184
2025
Q3 		$1.82M Buy
71,349
+9,436
+15% +$233K 0.1% 170
2025
Q2 		$1.5M Sell
61,913
-1,218
-2% -$28.4K 0.09% 187
2025
Q1 		$1.6M Buy
63,131
+25,785
+69% +$675K 0.12% 155
2024
Q4 		$991K Sell
37,346
-2,558
-6% -$69.4K 0.08% 209
2024
Q3 		$1.15M Buy
39,904
+13,097
+49% +$382K 0.11% 168
2024
Q2 		$750K Buy
26,807
+13,039
+95% +$359K 0.1% 178
2024
Q1 		$382K Buy
13,768
+1,149
+9% +$31.9K 0.08% 243
2023
Q4 		$342K Buy
+12,619
New +$381K 0.09% 190

Other funds holding PFE

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return
WF
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

GAMMA Investing's PFE Position: Q3 2026 in Review

GAMMA Investing increased its Pfizer (PFE) stake by 25% in Q3 2026, buying an estimated $573K and bringing the position to 107,263 shares worth $3.06M. The position accounts for 0.1% of the portfolio, ranked #152.

GAMMA Investing first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • GAMMA Investing held 107,263 shares of Pfizer worth $3.06M as of Q3 2026.
  • GAMMA Investing bought 21,561 Pfizer shares in Q3 2026, an estimated $573K.
  • Pfizer made up 0.1% of GAMMA Investing's portfolio in Q3 2026, its #152 holding.
  • GAMMA Investing first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.